Aberdeen Group’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $91.5M | Buy |
230,411
+15,376
| +7% | +$4.38M | 0.13% | 137 |
|
|
2026
Q1 | $37.3M | Sell |
215,035
-68,743
| -24% | -$14.1M | 0.06% | 269 |
|
|
2025
Q4 | $72.7M | Buy |
283,778
+43,442
| +18% | +$11.4M | 0.11% | 148 |
|
|
2025
Q3 | $62.5M | Buy |
240,336
+68,175
| +40% | +$17.9M | 0.1% | 170 |
|
|
2025
Q2 | $41.8M | Buy |
172,161
+40,492
| +31% | +$10.1M | 0.07% | 236 |
|
|
2025
Q1 | $34.7M | Buy |
131,669
+5,809
| +5% | +$1.57M | 0.07% | 249 |
|
|
2024
Q4 | $31.9M | Buy |
125,860
+16,612
| +15% | +$4.46M | 0.06% | 286 |
|
|
2024
Q3 | $35M | Sell |
109,248
-14,452
| -12% | -$5.14M | 0.06% | 273 |
|
|
2024
Q2 | $46.2M | Sell |
123,700
-55,735
| -31% | -$18.8M | 0.09% | 224 |
|
|
2024
Q1 | $62.2M | Sell |
179,435
-13,165
| -7% | -$4.99M | 0.12% | 177 |
|
|
2023
Q4 | $88.2M | Buy |
192,600
+106,586
| +124% | +$52.5M | 0.19% | 122 |
|
|
2023
Q3 | $41.8M | Buy |
86,014
+2,148
| +3% | +$1.01M | 0.11% | 182 |
|
|
2023
Q2 | $37.5M | Buy |
83,866
+8,467
| +11% | +$4.26M | 0.09% | 220 |
|
|
2023
Q1 | $36.6M | Buy |
75,399
+3,502
| +5% | +$1.73M | 0.09% | 225 |
|
|
2022
Q4 | $36.8M | Buy |
71,897
+9,848
| +16% | +$5.18M | 0.1% | 225 |
|
|
2022
Q3 | $30.1M | Buy |
62,049
+20,135
| +48% | +$9.79M | 0.09% | 240 |
|
|
2022
Q2 | $19.7M | Buy |
41,914
+1,547
| +4% | +$688K | 0.06% | 290 |
|
|
2022
Q1 | $18M | Sell |
40,367
-12,148
| -23% | -$5.08M | 0.05% | 324 |
|
|
2021
Q4 | $24.4M | Sell |
52,515
-4,509
| -8% | -$2M | 0.05% | 304 |
|
|
2021
Q3 | $22.3M | Sell |
57,024
-1,775
| -3% | -$753K | 0.05% | 325 |
|
|
2021
Q2 | $26M | Sell |
58,799
-6,218
| -10% | -$2.72M | 0.06% | 297 |
|
|
2021
Q1 | $27.3M | Buy |
65,017
+2,263
| +4% | +$903K | 0.06% | 281 |
|
|
2020
Q4 | $25.7M | Sell |
62,754
-4,057
| -6% | -$1.69M | 0.06% | 270 |
|
|
2020
Q3 | $27.7M | Sell |
66,811
-10,014
| -13% | -$4.03M | 0.07% | 217 |
|
|
2020
Q2 | $29.8M | Sell |
76,825
-17,453
| -19% | -$6.53M | 0.08% | 220 |
|
|
2020
Q1 | $29.6M | Buy |
94,278
+5,347
| +6% | +$1.8M | 0.09% | 180 |
|
|
2019
Q4 | $32.6M | Buy |
88,931
+14,875
| +20% | +$4.72M | 0.08% | 225 |
|
|
2019
Q3 | $18.9M | Sell |
74,056
-17,726
| -19% | -$4.97M | 0.05% | 331 |
|
|
2019
Q2 | $24.4M | Sell |
91,782
-4,726
| -5% | -$1.2M | 0.05% | 327 |
|
|
2019
Q1 | $25.7M | Sell |
96,508
-71,561
| -43% | -$20.6M | 0.06% | 307 |
|
|
2018
Q4 | $47.8M | Sell |
168,069
-72,318
| -30% | -$22.9M | 0.11% | 151 |
|
|
2018
Q3 | $81.4M | Sell |
240,387
-6,559
| -3% | -$2.13M | 0.15% | 135 |
|
|
2018
Q2 | $73.5M | Sell |
246,946
-8,905
| -3% | -$2.61M | 0.14% | 138 |
|
|
2018
Q1 | $68.8M | Buy |
255,851
+18,258
| +8% | +$4.94M | 0.14% | 155 |
|
|
2017
Q4 | $59M | Buy |
237,593
+19,710
| +9% | +$4.87M | 0.11% | 178 |
|
|
2017
Q3 | $53.1M | Buy |
+217,883
| New | +$53.4M | 0.1% | 201 |
|
Other funds holding HUM
SC
Aberdeen Group's HUM Position: Q2 2026 in Review
Aberdeen Group increased its Humana (HUM) stake by 7.2% in Q2 2026, buying an estimated $4.38M and bringing the position to 230,411 shares worth $91.5M. The position accounts for 0.13% of the portfolio, ranked #137.
Aberdeen Group first reported a position in HUM in Q3 2017 and has held it in 36 quarters since. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Aberdeen Group held 230,411 shares of Humana worth $91.5M as of Q2 2026.
- Aberdeen Group bought 15,376 Humana shares in Q2 2026, an estimated $4.38M.
- Humana made up 0.13% of Aberdeen Group's portfolio in Q2 2026, its #137 holding.
- Aberdeen Group first reported a position in Humana in Q3 2017 and has held it in 36 quarters since.
- 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.